M.‐S. Katsarou, K. Karakonstantis, N. Demertzis, E. Vourakis, A. Skarpathioti, A. E. Nosyrev, A. Tsatsakis, T. Kalogridis, N. Drakoulis. Effect of single‐nucleotide polymorphisms in *ADH1B*,*ADH4*,*ADH1C*,*OPRM1*,*DRD2*,*BDNF*, and *ALDH2* genes on alcohol dependence in a Caucasian population. Pharma Res Per, 5(4), 2017, e00326, <https://doi.org/10.1002/prp2.326>

ADH1B

:   subunit 1B of the ADH gene

ADH4

:   alcohol dehydrogenase 4
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:   alcohol dehydrogenase

ALDH

:   aldehyde dehydrogenase
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:   ankyrin repeat and kinase‐containing 1

BDNF

:   brain‐derived neurotrophic factor

CNS

:   central nervous system
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:   Hardy--Weinberg equilibrium

MOR

:   μ‐opioid receptors

OPRM1

:   μ‐opioid receptor gene

ORs

:   odd ratios

PCR

:   polymerase chain reaction

SNPs

:   single‐nucleotide polymorphisms

TGS

:   total genotype score

Introduction {#prp2326-sec-0001}
============

Alcohol is one of the most frequently used addictive substances in the world, causing physical and psychological dependence. According to the World Health Organization, alcohol misuse may be the cause of over 3.3 million deaths per year globally. Additionally, excessive use of alcohol may cost more than 249 billion U.S. dollars per year, only in the United States (Sacks et al. [2015](#prp2326-bib-0024){ref-type="ref"}). In the European Union the alcohol abuse issue seems to be quite important, as it shows the highest proportion of alcoholics and the highest levels of alcohol consumption per capita in the world and, therefore, the highest level of alcohol‐related health problems.

Alcohols\' sedative effects on the central nervous system (CNS) are presented in cerebral cortex and reticular formation through a complex mode of action (Contet et al. [2004](#prp2326-bib-0006){ref-type="ref"}; Zaleski et al. [2004](#prp2326-bib-0033){ref-type="ref"}). Furthermore, alcohol leads to increased dopamine release in the mesolimbic pathway, through increased release of beta‐endorphin which is binding to *μ*‐opioid receptors (MOR), inducing activation of the reward pathway, leading to alcohol dependence (Chatterjee et al. [2011](#prp2326-bib-0005){ref-type="ref"}; Rahman and Prendergast [2012](#prp2326-bib-0022){ref-type="ref"}; Wu et al. [2014](#prp2326-bib-0031){ref-type="ref"}; Berrettini [2016](#prp2326-bib-0002){ref-type="ref"}).

Alcohol biodegradation is performed mainly in liver through consecutive oxidation steps. It is converted into acetaldehyde by alcohol dehydrogenase (ADH) and then into acetic acid by aldehyde dehydrogenase (ALDH) (Hurley et al. [2002](#prp2326-bib-0010){ref-type="ref"}; Zakhari [2006](#prp2326-bib-0032){ref-type="ref"}).

Genetic differences have been associated with differences in alcohol response among individuals. The studied single‐nucleotide polymorphisms (SNPs) were rs1229984 (*ADH1B*), rs1693482 (*ADH1C*), rs1799971 (*OPRM1*), rs1800497 (*DRD2*), rs1800759 (*ADH4*), rs6265 (*BDNF*), and rs671 (*ALDH2*).

The polymorphism rs1229984 (His48Arg) resides at the subunit 1B of the gene encoding ADH (*ADH1B*). The allele incorporating this SNP is referred as *ADH1B\*2* and leads to differentiation in enzyme activity. Carriers of G:A or A:A genotype appear to have increased activity of ADH, therefore, metabolizing alcohol faster than carriers of G:G genotype (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}).

The polymorphism rs1693482 (Arg272Gln) of the *ADH1C* subunit is located on chromosome 4. Homozygous or heterozygous presence of the mutant *ADH1C\*2* allele limits the rate of alcohol metabolism and may show increased risk for alcohol dependence due to lower blood acetaldehyde levels (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}).

Another polymorphism, considered to be participating in alcohol absorption and its biotransformation distribution (usually when alcohol blood levels are elevated) is rs1800759 that represents an SNP located in the promoter region of alcohol dehydrogenase 4 gene *(ADH4)*. This variation causes increased gene transcription and, thus, increased enzyme biosynthesis that leads to heavy drinking. (Luo et al. [2006](#prp2326-bib-0016){ref-type="ref"}, [2007](#prp2326-bib-0017){ref-type="ref"}; Kimura et al. [2009](#prp2326-bib-0012){ref-type="ref"}).

Finally, the rs671 polymorphism (Glu504Lys), of the gene encoding for *ALDH2*, has been reported to generate an inactive allele (*ALDH2\*2*). Heterozygous *ALDH2\*1/\*2* (G:A) individuals experience reduced ALDH2 enzyme activity and homozygous polymorphism *ALDH2\*2/\*2* (A:A) carriers are characterized by lack of ALDH2 enzyme activity (Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}).

While deficiencies in alcohol metabolizing enzymes may have a protective effect on alcohol dependence, genetic alterations in neurotransmission‐associated genes may affect activation or deactivation of the reward pathway in the CNS, providing a protective alcohol dependence mechanism.

A variation located in the *μ*‐opioid receptor gene (*OPRM1*), the rs1799971 (Asn40Asp), is reported to increase the binding affinity of the receptor for beta‐endorphins (Bart et al. [2005](#prp2326-bib-0001){ref-type="ref"}; Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}). This substitution seems to have a significant effect on the mesolimbic pathway in CNS (Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}; van den Wildenberg et al. [2007](#prp2326-bib-0028){ref-type="ref"}; Ehlers et al. [2008](#prp2326-bib-0007){ref-type="ref"}).

The *TaqI*Α polymorphism (rs1800497) lies more than 10 kb downstream of the *DRD2* gene. It is associated with a reduced DRD2 binding and density and its A1 allele is associated with alcoholism (Munafo et al. [2007](#prp2326-bib-0020){ref-type="ref"}). Moreover, it is known that this polymorphism is located in the coding region of the *ankyrin repeat* and *kinase‐containing 1* (*ANKK1*) gene, encoding an enzyme that belongs to the serine/threonine kinases family, and results in a glutamic acid to lysine substitution in residue 713 (Glu713Lys), located at the carboxyl terminal ankyrin repeat domain, in a position associated with interactions between proteins (Huang et al. [2009](#prp2326-bib-0009){ref-type="ref"}; Kraschewski et al. [2009](#prp2326-bib-0013){ref-type="ref"}).

Lastly, the rs6265 polymorphism (Val66Met), in the gene encoding for *Brain‐Derived Neurotrophic Factor* (*BDNF*), is located in the 5′ pro‐BDNF sequence. Although this BDNF polymorphism does not affect mature BDNF protein function, it has been shown to alter the intracellular tracking and packaging of pro‐BDNF and, thus, to affect the regulated secretion of the mature peptide. BDNF may modulate the activity of various neurotransmitters, such as serotonin and dopamine (Gratacos et al. [2007](#prp2326-bib-0008){ref-type="ref"}; Wojnar et al. [2009](#prp2326-bib-0030){ref-type="ref"}).

This study aims at associating SNPs with alcohol dependence development, by determining their occurrence rates in a southeastern European Caucasian population sample and estimating the total risk of dependence by calculating the total number of alcohol‐associated SNPs for each volunteer.

Subjects and Methods {#prp2326-sec-0002}
====================

Samples from 690 women (54.08%) and 586 men (45.92%) (Southeastern European general population of unrelated Caucasians living in Greece, *n* = 1276) were analyzed. The median age of the participants was 35 years and their ages ranged from 18 to 97 years. Data collected from participants include gender, date of birth, place of residence, and genotype for genes of interest. No additional information on volunteers\' health status and dependence on alcohol or any other addictive substances was provided.

The study was approved by the Ethics Committee of the University of Crete (University Hospital of Heraklion Ethics Committee Decision 8195/16) for blood sampling in patients and controls for biochemical and molecular cloning. All participants gave written informed consent to use their data following deidentification and data anonymization.

Epithelial cells were collected from the oral cavity of each volunteer using cotton swabs and DNA extraction was performed using nucleic acid isolation columns. Genotypes were determined by real‐time Polymerase Chain Reaction (PCR), using the LightCycler480 Instrument platform and following LightSnip kit protocols (Roche Diagnostics, Switzerland). Genotypes were classified as homozygous for wild‐type alleles, heterozygous and homozygous for mutant alleles.

Contingency tables 2 × 2 (1 degree of freedom) were designed and odd ratios (ORs) for elevated alcohol risk polymorphisms, as well as the corresponding confidence intervals were calculated. Statistical analysis was performed at a significant level of *a* = 0.05 and a statistically significance *p*‐value was calculated by Fisher\'s exact test. All genotypes were tested for Hardy--Weinberg equilibrium (HWE) using web‐based software (<http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2-alleles.html>).

For the calculation of dependence susceptibility arising from the combined influence of alcohol‐associated SNPs, the following algorithm was used (Williams and Folland [2008](#prp2326-bib-0029){ref-type="ref"}):

TGS = (100/2xN) × (GS~1 ~+ GS~2 ~+ .... + GS~N~), where Total Genotype Scores of addiction (TGS) represents the total risk of developing dependence on alcohol. N stands for the number of SNPs associated with the dependence on alcohol and GS (Genotype Score) is the score of each genotype, ranging from 0 to 2, according to the number of susceptible alleles (score 2: two susceptible alleles associated with risk of dependence, score 0: no susceptible allele associated with risk for dependence, and score 1: heterozygous genotype, only one susceptible allele associated with risk for dependence, Table [1](#prp2326-tbl-0001){ref-type="table-wrap"}).

###### 

Total genotype score--grading (TGS‐Grading) for alcohol dependence genes

  SNP         Homozygous wild type   Heterozygous   Homozygous mutated   Risk of alcohol dependence   Reference
  ----------- ---------------------- -------------- -------------------- ---------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  rs1229984   +2                     +1             0                    Decreased                    (Chatterjee et al. [2011](#prp2326-bib-0005){ref-type="ref"}; Feduccia et al. [2012](#prp2326-bib-0500){ref-type="ref"})
  rs1693482   0                      +1             +2                   Increased                    (Chatterjee et al. [2011](#prp2326-bib-0005){ref-type="ref"}; Feduccia et al. [2012](#prp2326-bib-0500){ref-type="ref"})
  rs1800759   0                      +1             +2                   Increased                    (Hendrickson et al. [2009](#prp2326-bib-0501){ref-type="ref"}, 2011; Herz [1997](#prp2326-bib-0503){ref-type="ref"})
  rs671       +2                     +1             0                    Decreased                    (Bart et al. [2005](#prp2326-bib-0001){ref-type="ref"}; Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}; Chatterjee et al. [2011](#prp2326-bib-0005){ref-type="ref"}; Ehlers et al. [2008](#prp2326-bib-0007){ref-type="ref"})
  rs1799971   0                      +1             +2                   Increased                    (Munafo et al. [2007](#prp2326-bib-0020){ref-type="ref"}; Rahman [2013](#prp2326-bib-0504){ref-type="ref"}; Rahman and Prendergast [2012](#prp2326-bib-0022){ref-type="ref"}; Tizabi et al. [2002](#prp2326-bib-0505){ref-type="ref"}; Wu et al. [2014](#prp2326-bib-0031){ref-type="ref"})
  rs1800497   0                      +1             +2                   Increased                    (Hurley et al. [2002](#prp2326-bib-0010){ref-type="ref"}; Zakhari [2006](#prp2326-bib-0032){ref-type="ref"})
  rs6265      +2                     +1             0                    Decreased                    (Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}; Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"})
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Results {#prp2326-sec-0003}
=======

Data collected for polymorphism rs1229984 showed that 64.14% of the 1276 volunteers were homozygous for the wild type (G:G). Polymorphism rs1229984 was in HWE in the volunteer population of this study (*x* ^2 ^= 0.63) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

###### 

Comparative frequency and distribution rates of alleles and genotypes of the rs1229984 (*ADH1B*), rs1693482 (*ADH1C*), rs1800759 (*ADH4*), rs671 (*ALDH2*), rs1799971 (*OPRM1*), rs1800497 (*DRD2*), and rs6265 (*BDNF*) polymorphisms in a global, a European, and a Greek population (<http://browser.1000genomes.org>)

              Population   \% Allele   \% Genotype                   
  ----------- ------------ ----------- ------------- ------- ------- -----
  rs1229984                G           A             G:G     G:A     A:A
  Global      84.15        15.85       78.24         11.82   9.94    
  European    97.12        2.88        94.43         5.37    0.20    
  Greek       81.07        18.93       66.14         29.86   4.00    
  rs1693482                C           T             C:C     C:T     T:T
  Global      78.57        21.43       63.78         29.59   6.63    
  European    59.54        40.46       37.57         43.94   18.49   
  Greek       75.82        24.18       57.44         36.76   5.80    
  rs1800759                C           A             C:C     C:A     A:A
  Global      56.21        43.79       38.90         34.62   26.48   
  European    60.44        39.56       35.79         49.30   14.91   
  Greek       41.69        58.31       17.63         48.12   34.25   
  rs671                    G           A             G:G     G:A     A:A
  Global      96.43        3.57        93.65         5.55    0.80    
  European    100          0           100           0       0       
  Greek       99.92        0.08        99.84         0.16    0       
  rs1799971                G           A             G:G     G:A     A:A
  Global      22.34        77.66       7.15          30.39   62.46   
  European    16.20        83.80       2.58          27.24   70.18   
  Greek       14.73        85.27       1.88          25.69   72.43   
  rs1800497                C           T             C:C     C:T     T:T
  Global      67.43        32.57       46.57         41.73   11.70   
  European    81.21        18.79       67.00         28.43   4.57    
  Greek       84.43        15.57       70.84         27.18   1.98    
  rs6265                   G           A             G:G     G:A     A:A
  Global      79.87        20.13       66.65         26.44   6.91    
  European    80.32        19.68       64.21         32.21   3.58    
  Greek       81.50        18.50       65.99         31.03   2.98    
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For polymorphism rs1693482, 94.21% of the volunteers were either homozygous for the wild‐type genotype (C:C) or heterozygous (C:T). HWE was calculated for this polymorphism in this study (*x* ^2 ^= 0.63) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

Data collected for polymorphism rs1800759 showed that 17.63% were homozygous for the mutant allele (A:A). HWE was detected for polymorphism rs1800759 as well (*x* ^2 ^= 0.1352) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

According to the data collected for the polymorphism rs671, the vast majority (99.84%) of the volunteers were homozygous for the wild‐type genotype (G:G). HWE could not be accurately determined for polymorphism rs671 due to small population sample used (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

For the polymorphism rs1799971 data were obtained from 1,273 volunteers. Of these, 27.58% were homozygous for the mutant genotype (G:G) or heterozygous (G:A). HWE was calculated for polymorphism rs1799971 (*x* ^2 ^= 0.6521) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

Data were obtained only from 1262 volunteers for polymorphism rs1800497. Of these, 29.16% were heterozygous (C:T) or homozygous for the mutant allele (T:T). Polymorphism rs1800497 was in HWE in this study (*x* ^2 ^= 1.4371) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

Finally, for polymorphism rs6265 data were obtained from 1273 volunteers. Of those, 65.69% were homozygous for the wild‐type genotype (G:G). HWE was detected for polymorphism rs6265 in the volunteer Greek population of our study (*x* ^2 ^= 1.0715) (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

No association between the polymorphisms rs1229984, rs1693482, rs1800759, rs671, rs1799971, rs1800497, and rs6265 and gender could be established.

TGS of addiction was calculated according to Table [1](#prp2326-tbl-0001){ref-type="table-wrap"}. The population of this study is normally distributed (Fig. [1](#prp2326-fig-0001){ref-type="fig"}). The population sample that had a TGS equal to or bigger than 50 was 92.09%, with only a few being in the very high‐risk group of TGS of 71‐100. Most volunteers participating in this study achieved TGSs between 20 and 70. Examining separately the SNPs for alcohol metabolism and the CNS, a right shift of the alcohol metabolism normal distribution curve and a left shift of the CNS normal distribution curve are observed. (Fig. [1](#prp2326-fig-0001){ref-type="fig"}G, H and I).

![Comparative distribution of the Total Genotype Score of addiction in the global, the European, and the Greek populations of this study (A, D, and G). Distribution of the TGS of addiction for the SNPs associated with alcohol metabolism (B/E/H). A right shift of the distribution can be seen. Distribution of the TGS of addiction for the SNPs associated with Central Nervous System (C/F/I). A left shift of the distribution can be seen. TGS values for global, European, and Greek populations of this study.](PRP2-5-e00326-g001){#prp2326-fig-0001}

Discussion {#prp2326-sec-0004}
==========

Alcohol abuse has a great social, as well as economic impact, as it may be responsible for inaptitude behaviors, such as reduced reflexes, which often lead to misjudgment of certain situations (<https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm>). Alcohol effects depend on many factors, one of the more important being the amount of alcohol consumed and how fast it is metabolized in the human body. Even though there are studies suggesting a beneficial effect of mild alcohol consumption (Hvidtfeldt et al. [2010](#prp2326-bib-0011){ref-type="ref"}; Brien et al. [2011](#prp2326-bib-0004){ref-type="ref"}; Ronksley et al. [2011](#prp2326-bib-0023){ref-type="ref"}), if this happens on a more regular basis, it will most likely lead to addiction (<https://www.drugabuse.gov/drugs-abuse/alcohol>). The possibility of developing alcohol addiction could be predicted by genetic predisposition analysis.

According to the literature, some of the studied genes are associated with increased risk of dependence, while others seem to be protective against alcohol dependence (Luu et al. [1995](#prp2326-bib-0018){ref-type="ref"}; Shen et al. [1997](#prp2326-bib-0025){ref-type="ref"}; Wall et al. [1997](#prp2326-bib-0027){ref-type="ref"}; Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Luo et al. [2006](#prp2326-bib-0016){ref-type="ref"}, [2007](#prp2326-bib-0017){ref-type="ref"}; Gratacos et al. [2007](#prp2326-bib-0008){ref-type="ref"}; Kimura et al. [2009](#prp2326-bib-0012){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}; Wojnar et al. [2009](#prp2326-bib-0030){ref-type="ref"}). In this study, the correlation between seven SNPs in genes, associated with the development of dependence on alcohol and their incidence was investigated. Then it was compared with published data for global and North (<http://browser.1000genomes.org/>).

The rs1229984 (*ADH1B*) polymorphism leads to a decreased risk for alcohol addiction (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}). The mutant allele (A) occurs in 15.85% of the global population and 2.88% of the European population. This study revealed an A allele of the population of this study, similar to that in the global population and much higher than that in the European population (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

###### 

Correlation of alcohol dependence, allele, and genotype distributions between Greek and global populations and between Greek and European populations for the polymorphisms rs1229984, rs1693482, rs1800759, rs671, rs1799971, rs1800497, and rs6265

                                   Gene        Polymorphism   Odds ratio      95% confidence interval   *P*
  -------------------------------- ----------- -------------- --------------- ------------------------- ----------
  Allele distribution                                                                                   
  Greek and global populations     *ADH1B*     rs1229984      0.80            0.71--0.91                0.0007
  *ADH1C*                          rs1693482   1.16           1.04--1.39      0.006                     
  *ADH4*                           rs1800759   0.91           0.83--1.01      n.s                       
  *ADLH2*                          rs671       47.26          11.70--190      \<0.0001                  
  *OPRM1*                          rs1799971   0.60           0.52--0.68      \<0.0001                  
  *DRD2*                           rs1800497   0.38           0.33--0.43      \<0.0001                  
  *BDNF*                           rs6265      1.11           0.98--1.25      n.s                       
  Greek and European populations   *ADH1B*     rs1229984      0.12            0.08--0.18                \<0.0001
  *ADH1C*                          rs1693482   0.46           0.40--0.54      \<0.0001                  
  *ADH4*                           rs1800759   1.09           0.93--1.27      n.s.                      
  *ADLH2*                          rs671       n.a.           n.a.            n.a.                      
  *OPRM1*                          rs1799971   0.89           0.72--1.09      n.s.                      
  *DRD2*                           rs1800497   0.79           0.65--0.96      0.02                      
  *BDNF*                           r s6265     1.07           0.89--1.30      n.s.                      
  Genotype distribution                                                                                 
  Greek and global populations     *ADH1B*     rs1229984      0.54            0.46--0.63                \<0.0001
  *ADH1C*                          rs1693482   1.30           1.13--1.49      0.0001                    
  *ADH4*                           rs1800759   0.59           0.49--0.70      \<0.0001                  
  *ADLH2*                          rs671       44.14          11.90--368.02   \<0.0001                  
  *OPRM1*                          rs1799971   0.62           0.53--0.72      \<0.0001                  
  *DRD2*                           rs1800497   0.35           0.30--0.41      \<0.0001                  
  *BDNF*                           rs6265      0.95           0.83--1.10      n.s.                      
  Greek and European populations   *ADH1B*     rs1229984      0.11            0.07--0.17                \<0.0001
  *ADH1C*                          rs1693482   0.44           0.35--0.55      \<0.0001                  
  *ADH4*                           rs1800759   1.21           0.90--1.63      n.s.                      
  *ADLH2*                          rs671       n.a.           n.a.            n.a.                      
  *OPRM1*                          rs1799971   0.87           0.69--1.11      n.s.                      
  *DRD2*                           rs1800497   0.83           0.66--1.04      n.s.                      
  *BDNF*                           rs6265      7              5.89--8.31      \<0.0001                  
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The genetic predisposition to developing alcohol addiction is reported to be lower for individuals carrying at least one mutant allele (G:A or A:A genotype) (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}). Those genotypes appear in 21.76% of the global population and in 5.57% of the European population. In the population of this study, the results revealed an increased frequency of combined genotypes G:A and A:A, as compared to both global and European populations. This observation may indicate a lower predisposition to developing alcohol addiction for Caucasians of southeast Europe (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Another polymorphism of the *ADH1* gene, rs1693482, increases alcohol addiction susceptibility (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}). The mutant allele (T) occurs worldwide at a rate of 21.43% and at a rate of 40.46% in Europe. The frequency of mutant T allele in the study population was similar to that in the global population, but much lower than that in the European population (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Thus, genetic predisposition to developing alcohol addiction is lower for those carrying the homozygous wild‐type C:C genotype (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}). This genotype is found in 63.78% of the global population and in 37.57% of the European population. In the population, of this study the results revealed a similar frequency compared to the global population, indicating a better alcohol addiction protection than that of other Caucasians living in the northern regions of Europe (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The rs1800759 (*ADH4*) polymorphism enhances the tendency to develop alcohol addiction (Luo et al. [2006](#prp2326-bib-0016){ref-type="ref"}, [2007](#prp2326-bib-0017){ref-type="ref"}; Kimura et al. [2009](#prp2326-bib-0012){ref-type="ref"}). The A allele appears in 43.79% of the global population, while in the European population, it is found at a rate of 39.56%. The frequency rate in this study population is higher than both populations (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The percentage of homozygous rs1800759 A:A carriers in the global population is 26.48 and in the European population 14.91, both lower than that of this study population. These carriers may be predisposed to consuming more alcohol and thus may have a higher risk of developing alcohol addiction (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}) (Luo et al. [2006](#prp2326-bib-0016){ref-type="ref"}, [2007](#prp2326-bib-0017){ref-type="ref"}; Kimura et al. [2009](#prp2326-bib-0012){ref-type="ref"}).

The rs671 (*ALDH2*) polymorphism leads to a decreased possibility to develop alcohol addiction (Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}). The mutant allele (A) occurs in 3.57% in the global population and seems to be completely absent in the European population. This study revealed the existence of A allele in the study population, in a rate close to that in the European population but much lower than that in the global population. The genetic predisposition to developing alcohol addiction may be lower for individuals carrying at least one mutant allele (G:A or A:A genotype) (Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}). Those genotypes appear in 6.35% of the global population, while they do not appear in the European population. In the population of this study, only one heterozygous carrier was detected (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The rs1799971 (*OPRM1*) polymorphism leads to an increased probability of developing alcohol addiction (Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}; van den Wildenberg et al. [2007](#prp2326-bib-0028){ref-type="ref"}; Ehlers et al. [2008](#prp2326-bib-0007){ref-type="ref"}). The mutant allele (A) occurs in 77.66% of the global population and in 83.80% of the European population. This study revealed an A allele frequency which is slightly higher when compared to both global and European populations (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Individuals carrying at least one *OPRM1* gene mutant allele (A) may enhance genetic predisposition to develop alcohol addiction (Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}; van den Wildenberg et al. [2007](#prp2326-bib-0028){ref-type="ref"}; Ehlers et al. [2008](#prp2326-bib-0007){ref-type="ref"}). Such genotypes appear in 92.85% of the global population and in 97.42% of the European population. In the population of this study, the results revealed increased prevalence of the heterozygous (G:A) and homozygous mutant (A:A) genotypes (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The rs1800497 polymorphism is associated with increased susceptibility to develop alcohol addiction (Munafo et al. [2007](#prp2326-bib-0020){ref-type="ref"}). The mutant allele (T) occurs in 32.57% of the global population and in 18.79% of the European population. The frequency of the T allele in this study population was similar to that of the European population (Table [2](#prp2326-tbl-0002){ref-type="table-wrap"}).

Developing alcohol addiction seems to be lower for individuals carrying the wild‐type C:C genotype. The existence of even one mutant allele seems to play a decisive role in the CNS reward pathway because dopaminergic neurotransmission is known to be essential for the alcohol mechanism of action (Munafo et al. [2007](#prp2326-bib-0020){ref-type="ref"}). The C:C genotype is found in 46.57% of the global population and in 67.00% of the European population. In this study, the results revealed an increased frequency of C:C genotype compared to both global and European populations. According to the participants of this study, it is obvious that the T allele is present twice as much in the global population, while homozygous mutated individuals (T:T) appear 2.5 times more frequent in the European than in the Greek population and more than 5 time more frequent in the global population (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The rs6265 (*BDNF*) polymorphism has been associated with decreased risk of alcohol dependence (Gratacos et al. [2007](#prp2326-bib-0008){ref-type="ref"}; Wojnar et al. [2009](#prp2326-bib-0030){ref-type="ref"}). The mutant allele (A) occurs in 20.13% of the global population and in 19.68% of the European population. This study revealed an A allele frequency similar to both populations (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The susceptibility to developing alcohol addiction is higher for individuals carrying the homozygous wild‐type G:G genotype of the rs6265 polymorphism (Gratacos et al. [2007](#prp2326-bib-0008){ref-type="ref"}; Wojnar et al. [2009](#prp2326-bib-0030){ref-type="ref"}). A percentage of 66.65 of the global population and 64.21 of the European population are homozygous for wild‐type G:G genotype. In the population of this study, the results revealed an increased prevalence of the homozygous wild‐type genotype G:G (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The prevalence of polymorphisms favoring alcohol dependence (rs1693482, rs1800759, rs1799971, and rs1800497), which may eventually lead to alcohol addiction in the South Eastern European Greek population, seems to be lower than the respective one in the Northern European populations (Lee et al. [2004](#prp2326-bib-0015){ref-type="ref"}; Berrettini and Lerman [2005](#prp2326-bib-0003){ref-type="ref"}; Luo et al. [2006](#prp2326-bib-0016){ref-type="ref"}, [2007](#prp2326-bib-0017){ref-type="ref"}; Munafo et al. [2007](#prp2326-bib-0020){ref-type="ref"}; van den Wildenberg et al. [2007](#prp2326-bib-0028){ref-type="ref"}; Ehlers et al. [2008](#prp2326-bib-0007){ref-type="ref"}; Kimura et al. [2009](#prp2326-bib-0012){ref-type="ref"}; Macgregor et al. [2009](#prp2326-bib-0019){ref-type="ref"}). According to these results, the Greek population may be more protected against addiction development.

According to the HWE law, genotype frequencies are functions of allele frequencies and a large random mating population is at equilibrium given that there is no migration, natural selection, or genetic drift (Namipashaki et al. [2015](#prp2326-bib-0021){ref-type="ref"}). In this study, HWE was detected for all polymorphisms except rs671. This could be interpreted as a stability regarding the mechanisms of evolution mentioned above, which means that evolution did not occur and, theoretically, the gene pool frequencies remained unaltered. However, it cannot safely be assumed that the next generations will also follow the HWE because evolution is an inevitable result. Moreover, it is important to note that for the rs671 polymorphism the chi square calculated was zero. This could possibly mean that the population sample used was too small to detect a Hardy--Weinberg disequilibrium for very rare polymorphisms.

In order to determine the existence of a significant difference between frequency distribution rates of the alleles and genotypes of Greek, global and European populations chi‐square test was conducted between those three populations, separately for the alleles and the genotypes that favor the development of alcohol addiction (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

The allele frequencies of this study population were significantly different (*P *\<* *0.05) when compared to the global population for polymorphisms rs1229984 (*ADH1B*), rs1799971 (*OPRM1*), rs1800497 (DR*D2*), rs1693482 (*ADH1C*), and rs671 (*ALDH2*). This study population seems to be better protected against alcohol addiction for polymorphisms rs1229984, rs1799971, and rs1800497, but seems to be more exposed to alcohol addiction compared to the global population due to their rs1693482 and rs671 genotype profile. (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Compared to the European population, the Greek population of this study is significantly different in polymorphisms rs1229984, rs1693482, and rs1800497. Thus, individuals of this study population seem to be more protected than their northern European counterparts (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Frequency distribution of rs1229984, rs1693482, rs1800759, rs671, rs1799971, rs1800497, and rs6265 genotypes in this study population was compared to the respective frequency distribution of the northern European and the global population. The population of this study seems to be significantly more protected against alcohol addiction for polymorphisms rs1229984, rs1800759, rs1799971, rs1800497, but significantly more exposed to alcohol addiction due to their genotypic profile of polymorphisms rs1693482 and rs671, when compared to the global population (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Compared to the European population, the Greek population appeared to be more protected for polymorphisms rs1229984 and rs1693482, but seems to be more exposed to alcohol addiction due to their rs6265 genotype profile (Table [3](#prp2326-tbl-0003){ref-type="table-wrap"}).

Individuals generating TGS scores above 50 seem to have higher predisposition to alcohol addiction. Almost all volunteers of this study had TGS higher than 50, but only a small portion of the investigated population was in the very high‐risk group of TGS score between 71 and 100. The majority was concentrated in the medium‐risk region of 50--70 (Fig. [1](#prp2326-fig-0001){ref-type="fig"}).

Total genotype score for global and Northern European populations has been calculated. The results revealed that in both populations more than 80% have a TGS score higher than 50 (Fig. [1](#prp2326-fig-0001){ref-type="fig"}). Of the European population, 39.36% is in the very high‐risk group of TGS score between 71 and 100 and 57.26% is in the medium‐risk region of 50--70 (Fig. [1](#prp2326-fig-0001){ref-type="fig"}). In the global population, 27.96% are in the very high‐risk group of TGS score between 71 and 100 and 55.79% in the medium‐risk region of 50--70 (Fig. [1](#prp2326-fig-0001){ref-type="fig"}). These findings indicate that volunteers of this study population may be more protected against developing alcohol dependence, compared to the north European population, which are consistent with a recent study (Labhart et al. [2017](#prp2326-bib-0014){ref-type="ref"}).

Alcohol‐associated metabolic‐ and CNS‐polymorphism analysis in the global (Fig. [1](#prp2326-fig-0001){ref-type="fig"}A, B and C) and the European populations (Fig. [1](#prp2326-fig-0001){ref-type="fig"}D, E and F) revealed a right shift of the alcohol metabolism normal distribution curve and a left shift of the CNS normal distribution curve, similar -- but less distinguishable -- to the Greek sample population of this study (Fig. [1](#prp2326-fig-0001){ref-type="fig"}G, H and I). This finding indicates a greater impact of alcohol metabolism polymorphisms than CNS polymorphisms on TGS.

Conclusions {#prp2326-sec-0005}
===========

The investigated Southeastern population of this study may differ when compared to global and other European populations. In some of the studied SNPs there is a greater similarity to the global population \[rs1229984 (*ADH1B*), rs1693482 (*ADH1C*), and rs1800759 (*ADH4*)\], whereas in other polymorphisms, there is more similarity to the European population \[rs671 (*ALDH2*), rs1799971 (*OPRM1*), rs1800497 (*DRD2*), and rs6265 (*BDNF*)\]. The geographical position of Greece, on the crossroad between three continents (Europe, Asia, and Africa), could provide a plausible explanation for genetic influences from Asian and African populations on the Greek population.

The extremely low incidence (0.08%) of rs671 polymorphism in *ALDH2* gene in the population of this study seems to be rather important. Polymorphism rs671 has been associated with reduced desire for alcohol consumption and protective role against alcohol dependence (Takeuchi et al. [2011](#prp2326-bib-0026){ref-type="ref"}). Another noteworthy finding is the incidence of rs1800759 polymorphism of *ADH4 gene*, related to increased alcohol consumption, is rather high in comparison with other SNPs.

The investigation of polymorphisms associated with dependence could be useful in the prevention of alcohol dependence development. TGS calculation may predict individual response to alcohol, as it enables to identify potential alteration in the alcohol mechanism of action and biotransformation, providing additional tools in dependence prevention.

Analysis of alcohol‐associated genetic polymorphisms may also be valuable for the treatment of alcohol withdrawal symptoms, enabling the prediction of the most effective therapeutic method or agent for each individual. In addition, SNPs may be useful tools to predict the potential posttreatment relapse risk.

Limitations of the study {#prp2326-sec-0006}
------------------------

Further larger‐scale investigations may be needed in order to precisely determine alcohol‐associated polymorphisms incidence rates and to correlate them with alcohol dependence. Furthermore, in order to adjust the TGS algorithm, larger population studies for each alcohol addiction relevant gene may be necessary to better scale alcohol dependence susceptibility by TGS. This would enable accurate prediction of alcohol addiction developing prevalence to serve as individualized prevention tool.

This study was conducted in a general population. Further studies should be initialized to investigate the frequency distribution of these polymorphisms in alcohol addicted individuals. TGS was calculated assuming equal impact of each polymorphism to the score. In following studies, each polymorphism score should be weighted according to its contribution to alcohol dependence development. This would enhance the results and provide a more accurate tool for the physicians.
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